Purdue Pharma unveils $10bn opioid settlement plan to exit from bankruptcy

  • Plan is backed by $4bn from Sackler family
  • Most parties onboard but Democratic attorneys general oppose

Purdue Pharma is proposing a $10bn plan to emerge from bankruptcy that calls for it to be transformed into a company funnelling profits into the fight against the opioid crisis.

Those efforts would include a significant boost – more than $4bn – from members of the Sackler family who own the Connecticut-based pharmaceutical giant.

Related: McKinsey agrees $600m settlement over role in opioids crisis

Continue reading…

Purdue Pharma unveils $10bn opioid settlement plan to exit from bankruptcy

  • Plan is backed by $4bn from Sackler family
  • Most parties onboard but Democratic attorneys general oppose

Purdue Pharma is proposing a $10bn plan to emerge from bankruptcy that calls for it to be transformed into a company funnelling profits into the fight against the opioid crisis.

Those efforts would include a significant boost – more than $4bn – from members of the Sackler family who own the Connecticut-based pharmaceutical giant.

Related: McKinsey agrees $600m settlement over role in opioids crisis

Continue reading…